Stockreport

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com
PDF Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent PharmaceuticalsThe strategic agreement is in alignment w [Read more]